Trillium Therapeutics Inc (TRIL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2006 | 06-2006 | 03-2006 | 12-2005 | 09-2005 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 64 | 67 | 61 | 61 | 66 |
| Accounts receivable | -1 | 10 | -3 | 0 | 0 |
| Other Working Capital | 40 | -586 | -2 | 274 | 99 |
| Other Operating Activity | -1,031 | -980 | -850 | -1,084 | -622 |
| Operating Cash Flow | $-928 | $-1,489 | $-793 | $-749 | $-458 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -5 | 5 | -10 |
| Purchase Of Investment | N/A | N/A | N/A | 0 | -1 |
| Other Investing Activity | 0 | -1 | 0 | -3 | 0 |
| Investing Cash Flow | $0 | $-1 | $-5 | $2 | $-11 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 40 | 5 | 45 | 328 |
| Other Financing Activity | -360 | -2 | -2 | 249 | -410 |
| Financing Cash Flow | $-361 | $37 | $3 | $293 | $-82 |
| Beginning Cash Position | 2,734 | 3,966 | 4,762 | 5,233 | 5,765 |
| End Cash Position | 1,433 | 2,734 | 3,966 | 4,780 | 5,233 |
| Net Cash Flow | $-1,289 | $-1,453 | $-795 | $-454 | $-550 |
| Free Cash Flow | |||||
| Operating Cash Flow | -928 | -1,489 | -793 | -749 | -458 |
| Capital Expenditure | N/A | N/A | -5 | N/A | -10 |
| Free Cash Flow | -928 | -1,489 | -798 | -749 | -467 |